_id
69131261ccc777a4e85d7f2d
Ticker
MAIA
Name
MAIA Biotechnology Inc.
Exchange
NYSE MKT
Address
444 West Lake Street, Chicago, IL, United States, 60606
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://maiabiotech.com
Description
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Last Close
1.57
Volume
831262
Current Price
1.63
Change
0.07
Last Updated
2026-01-05T10:04:07.998Z
Image
data:image/webp;base64,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
Ipo Date
2022-07-28T00:00:00.000Z
Market Cap
59251692
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.91475
Sentiment Sources
4
Rating
5
Target Price
12.135
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
9360926
Operating Income
-9360926
Interest Expense
0
Pretax Income
-8903189
Net Income
-8903189
Eps
-0.2681521896271309
Dividends Per Share
-
Shares Outstanding
37032307
Income Tax Expense
-
EBITDA
457737
Operating Margin
-
Total Other Income Expense Net
457737
Cash
10891736
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
11754936
Property Plant Equipment
-
Total Assets
11782021
Payables
3175641
Short Term Debt
-
Long Term Debt
-
Total Liabilities
11740351
Equity
41670
Bs_currency_symbol
USD
Depreciation
9360926
Change In Working Capital
4961770
Cash From Operations
-3486516
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
4234769
Net Change In Cash
747214
Cf_currency_symbol
USD
PE
-
PB
1298.7583393328534
ROE
-21365.94432445404
ROA
-75.56588975694407
FCF
-3486516
Fcf Percent
-
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
9360926
Quarters > 0 > income Statement > operating Income
-9360926
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-8903189
Quarters > 0 > income Statement > net Income
-8903189
Quarters > 0 > income Statement > eps
-0.2681521896271309
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
33202000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
457737
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
457737
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10891736
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11754936
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
11782021
Quarters > 0 > balance Sheet > payables
3175641
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
11740351
Quarters > 0 > balance Sheet > equity
41670
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-8903188
Quarters > 0 > cash Flow > depreciation
9360926
Quarters > 0 > cash Flow > change In Working Capital
4961770
Quarters > 0 > cash Flow > cash From Operations
-3486516
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
4234769
Quarters > 0 > cash Flow > net Change In Cash
747214
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.2681521896271309
Quarters > 0 > ratios > PB
1298.7583393328534
Quarters > 0 > ratios > ROE
-21365.94432445404
Quarters > 0 > ratios > ROA
-75.56588975694407
Quarters > 0 > ratios > FCF
-3486516
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5166058
Quarters > 1 > income Statement > operating Income
-5166058
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5346963
Quarters > 1 > income Statement > net Income
-5346963
Quarters > 1 > income Statement > eps
-0.1764654514261375
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
30300339
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5166058
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-180905
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
10144522
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
82272
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
11043054
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
11045854
Quarters > 1 > balance Sheet > payables
1723163
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7169170
Quarters > 1 > balance Sheet > equity
3876684
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5346963
Quarters > 1 > cash Flow > depreciation
5166058
Quarters > 1 > cash Flow > change In Working Capital
86219
Quarters > 1 > cash Flow > cash From Operations
-4135337
Quarters > 1 > cash Flow > capital Expenditures
4
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3408190
Quarters > 1 > cash Flow > net Change In Cash
-718774
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.1764654514261375
Quarters > 1 > ratios > PB
12.740154361304661
Quarters > 1 > ratios > ROE
-137.92620187768722
Quarters > 1 > ratios > ROA
-48.40696789944897
Quarters > 1 > ratios > FCF
-4135341
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
5425431
Quarters > 2 > income Statement > operating Income
-5425431
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4517259
Quarters > 2 > income Statement > net Income
-4517259
Quarters > 2 > income Statement > eps
-0.16309560602231288
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27697000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-5425431
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
908172
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10863296
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
78084
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
11861852
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
11864652
Quarters > 2 > balance Sheet > payables
1841369
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6922127
Quarters > 2 > balance Sheet > equity
4942525
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4517259
Quarters > 2 > cash Flow > depreciation
5425000
Quarters > 2 > cash Flow > change In Working Capital
769502
Quarters > 2 > cash Flow > cash From Operations
-4202274
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
5461216
Quarters > 2 > cash Flow > net Change In Cash
1261998
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.16309560602231288
Quarters > 2 > ratios > PB
9.134219857259193
Quarters > 2 > ratios > ROE
-91.39577442703882
Quarters > 2 > ratios > ROA
-38.07325322310338
Quarters > 2 > ratios > FCF
-4202278
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
5004604
Quarters > 3 > income Statement > operating Income
-5004604
Quarters > 3 > income Statement > interest Expense
28
Quarters > 3 > income Statement > pretax Income
-3571938
Quarters > 3 > income Statement > net Income
-3571938
Quarters > 3 > income Statement > eps
-0.13655241226393455
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
26158000
Quarters > 3 > income Statement > income Tax Expense
-28107
Quarters > 3 > income Statement > EBITDA
-3571966
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1432666
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
9601298
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
77347
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
10152479
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
10155279
Quarters > 3 > balance Sheet > payables
1512436
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6520643
Quarters > 3 > balance Sheet > equity
3634636
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3571938
Quarters > 3 > cash Flow > depreciation
5004604
Quarters > 3 > cash Flow > change In Working Capital
227077
Quarters > 3 > cash Flow > cash From Operations
-3908175
Quarters > 3 > cash Flow > capital Expenditures
5
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
4845463
Quarters > 3 > cash Flow > net Change In Cash
910514
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.13655241226393455
Quarters > 3 > ratios > PB
11.730896849093003
Quarters > 3 > ratios > ROE
-98.2749854455852
Quarters > 3 > ratios > ROA
-35.173213852617934
Quarters > 3 > ratios > FCF
-3908180
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
16957210
Annuals > 0 > income Statement > operating Income
-16957210
Annuals > 0 > income Statement > interest Expense
57
Annuals > 0 > income Statement > pretax Income
-23254656
Annuals > 0 > income Statement > net Income
-23254656
Annuals > 0 > income Statement > eps
-1.0476242004905323
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
22197517
Annuals > 0 > income Statement > income Tax Expense
-79954
Annuals > 0 > income Statement > EBITDA
-23254599
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-6297446
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9601298
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
77347
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10152479
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
10155279
Annuals > 0 > balance Sheet > payables
1512436
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6520643
Annuals > 0 > balance Sheet > equity
3634636
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-23254656
Annuals > 0 > cash Flow > depreciation
6297503
Annuals > 0 > cash Flow > change In Working Capital
-1237749
Annuals > 0 > cash Flow > cash From Operations
-15704461
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
18176609
Annuals > 0 > cash Flow > net Change In Cash
2450603
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.0476242004905323
Annuals > 0 > ratios > PB
9.7715499433781
Annuals > 0 > ratios > ROE
-639.8070123115492
Annuals > 0 > ratios > ROA
-228.99081354633387
Annuals > 0 > ratios > FCF
-15704461
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
20182381
Annuals > 1 > income Statement > operating Income
-20182381
Annuals > 1 > income Statement > interest Expense
6863
Annuals > 1 > income Statement > pretax Income
-19772905
Annuals > 1 > income Statement > net Income
-19772905
Annuals > 1 > income Statement > eps
-1.4909444276881314
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
13262000
Annuals > 1 > income Statement > income Tax Expense
-176719
Annuals > 1 > income Statement > EBITDA
-19766042
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
409476
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7150695
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
144680
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7564052
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
7566852
Annuals > 1 > balance Sheet > payables
1638546
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7089341
Annuals > 1 > balance Sheet > equity
477511
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-19772905
Annuals > 1 > cash Flow > depreciation
2
Annuals > 1 > cash Flow > change In Working Capital
3086054
Annuals > 1 > cash Flow > cash From Operations
-13071016
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
9270901
Annuals > 1 > cash Flow > net Change In Cash
-3800232
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.4909444276881314
Annuals > 1 > ratios > PB
44.437091501557035
Annuals > 1 > ratios > ROE
-4140.827122307131
Annuals > 1 > ratios > ROA
-261.3095247534906
Annuals > 1 > ratios > FCF
-13071020
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
16176201
Annuals > 2 > income Statement > operating Income
-16176201
Annuals > 2 > income Statement > interest Expense
6967
Annuals > 2 > income Statement > pretax Income
-15769279
Annuals > 2 > income Statement > net Income
-15769279
Annuals > 2 > income Statement > eps
-1.6998252667888325
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
9277000
Annuals > 2 > income Statement > income Tax Expense
36689
Annuals > 2 > income Statement > EBITDA
-15762312
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
406922
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10950927
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
302789
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
11808037
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
12022040
Annuals > 2 > balance Sheet > payables
1165505
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3514247
Annuals > 2 > balance Sheet > equity
8507793
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-15769279
Annuals > 2 > cash Flow > depreciation
1
Annuals > 2 > cash Flow > change In Working Capital
352782
Annuals > 2 > cash Flow > cash From Operations
-12096104
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
12477169
Annuals > 2 > cash Flow > net Change In Cash
376635
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.6998252667888325
Annuals > 2 > ratios > PB
1.744659278851754
Annuals > 2 > ratios > ROE
-185.3509952581122
Annuals > 2 > ratios > ROA
-131.1697432382524
Annuals > 2 > ratios > FCF
-12096104
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
7786627
Annuals > 3 > income Statement > operating Income
-7786627
Annuals > 3 > income Statement > interest Expense
827539
Annuals > 3 > income Statement > pretax Income
-12578211
Annuals > 3 > income Statement > net Income
-12503880
Annuals > 3 > income Statement > eps
-1.1756292647996822
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
10635904
Annuals > 3 > income Statement > income Tax Expense
707530
Annuals > 3 > income Statement > EBITDA
-11750672
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-4791584
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10574292
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
43666
Annuals > 3 > balance Sheet > inventories
-43666
Annuals > 3 > balance Sheet > total Current Assets
10672495
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
11327199
Annuals > 3 > balance Sheet > payables
960401
Annuals > 3 > balance Sheet > short Term Debt
111271
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2145996
Annuals > 3 > balance Sheet > equity
9181203
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-12578211
Annuals > 3 > cash Flow > depreciation
7787000
Annuals > 3 > cash Flow > change In Working Capital
1125746
Annuals > 3 > cash Flow > cash From Operations
-4122896
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
14033731
Annuals > 3 > cash Flow > net Change In Cash
9910835
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.1756292647996822
Annuals > 3 > ratios > PB
1.853509436617402
Annuals > 3 > ratios > ROE
-136.18999601686184
Annuals > 3 > ratios > ROA
-110.38810212480597
Annuals > 3 > ratios > FCF
-4122896
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.2681521896271309
Valuation > metrics > PB
1298.7583393328534
Valuation > final Score
20
Valuation > verdict
43191.9% Overvalued
Profitability > metrics > ROE
-21365.94432445404
Profitability > metrics > ROA
-75.74000402894579
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
281.74588432925367
Risk > metrics > Interest Coverage
-1
Risk > final Score
2
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.7015947331578096
Liquidity > metrics > Quick Ratio
3.7015947331578096
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-84
Prev Risks > 1
6
Prev Risks > 2
-714913
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:10:22.721Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.13
Earnings History > 0 > eps Difference
0.13
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-27
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.27
Earnings History > 1 > eps Estimate
-0.19
Earnings History > 1 > eps Difference
-0.08
Earnings History > 1 > surprise Percent
-42.1053
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
-0.25
Earnings History > 2 > eps Difference
0.07
Earnings History > 2 > surprise Percent
28
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-09
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.16
Earnings History > 3 > eps Estimate
-0.18
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
11.1111
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.32
Earnings History > 4 > eps Estimate
-0.35
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
8.5714
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.355
Earnings History > 5 > eps Estimate
-0.47
Earnings History > 5 > eps Difference
0.115
Earnings History > 5 > surprise Percent
24.4681
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-19
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.5
Earnings History > 6 > eps Estimate
-0.415
Earnings History > 6 > eps Difference
-0.085
Earnings History > 6 > surprise Percent
-20.4819
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.46
Earnings History > 7 > eps Estimate
-0.39
Earnings History > 7 > eps Difference
-0.07
Earnings History > 7 > surprise Percent
-17.9487
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-21
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-2.5641
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.36
Earnings History > 9 > eps Estimate
-0.38
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
5.2632
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.35
Earnings History > 10 > eps Estimate
-0.38
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
7.8947
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.38
Earnings History > 11 > eps Estimate
-0.4
Earnings History > 11 > eps Difference
0.02
Earnings History > 11 > surprise Percent
5
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-24
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.43
Earnings History > 12 > eps Estimate
-0.41
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-4.878
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.49
Earnings History > 13 > eps Estimate
-0.49
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.07
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.07
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-12-22
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.02
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-1.02
Earnings History > 15 > surprise Percent
-
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMAIA 's Outlines 2026 Milestones On Ateganosine In Cancer Treatment Program; Stock Down - Nasdaq
1/21/2026
MAIA 's Outlines 2026 Milestones On Ateganosine In Cancer Treatment Program; Stock Down Nasdaq
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$12.135
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of MAIA Biotechnology Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.13
Date
2025-09-30
EPS Actual
-0.27
EPS Estimate
-0.19
EPS Difference
-0.08
Surprise Percent
-42.1053%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.